| Secondary |
| Drug Use For Unknown Indication |
26.5% |
| Hypertension |
17.6% |
| Product Used For Unknown Indication |
16.2% |
| Atrial Fibrillation |
4.4% |
| Atrial Flutter |
4.4% |
| Trigeminal Neuralgia |
4.4% |
| Antiinflammatory Therapy |
3.7% |
| Analgesic Therapy |
2.2% |
| Angina Pectoris |
2.2% |
| Depression |
2.2% |
| Drug Therapy |
2.2% |
| Hyperlipidaemia |
2.2% |
| Insomnia |
2.2% |
| Prinzmetal Angina |
2.2% |
| Prophylaxis |
2.2% |
| Essential Hypertension |
1.5% |
| Parkinson's Disease |
1.5% |
| Age-related Macular Degeneration |
0.7% |
| Antiplatelet Therapy |
0.7% |
| Blood Pressure |
0.7% |
|
| Poisoning |
13.2% |
| Ventricular Hypertrophy |
10.5% |
| Completed Suicide |
7.9% |
| Gingival Hyperplasia |
7.9% |
| Vomiting |
7.9% |
| Atrial Flutter |
5.3% |
| Renal Failure Acute |
5.3% |
| Respiratory Arrest |
5.3% |
| Tremor |
5.3% |
| Unresponsive To Stimuli |
5.3% |
| Accidental Exposure |
2.6% |
| Blood Potassium Increased |
2.6% |
| Cerebrovascular Accident |
2.6% |
| Cough |
2.6% |
| Drug Ineffective |
2.6% |
| Peptic Ulcer Haemorrhage |
2.6% |
| Peripheral Arterial Occlusive Disease |
2.6% |
| Renal Failure |
2.6% |
| Respiratory Depression |
2.6% |
| Syncope |
2.6% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
54.5% |
| Hypertension |
18.9% |
| Product Used For Unknown Indication |
9.0% |
| Diabetes Mellitus |
3.4% |
| Type 2 Diabetes Mellitus |
2.8% |
| Colorectal Cancer Metastatic |
1.8% |
| Dyslipidaemia |
1.2% |
| Atrial Fibrillation |
1.0% |
| Arteriosclerosis |
1.0% |
| Peritoneal Dialysis |
0.9% |
| Depression |
0.8% |
| Essential Hypertension |
0.6% |
| Pulmonary Hypertension |
0.6% |
| Prophylaxis |
0.6% |
| Hyperlipidaemia |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Prostate Cancer |
0.5% |
| Cardiac Failure |
0.5% |
| Hypercholesterolaemia |
0.4% |
| Cerebral Infarction |
0.3% |
|
| Death |
33.9% |
| Dyspnoea |
10.0% |
| Pneumonia |
8.9% |
| Pulmonary Arterial Hypertension |
4.1% |
| Renal Failure |
4.1% |
| Cerebrovascular Accident |
3.9% |
| Fall |
3.3% |
| Cardiac Failure Congestive |
3.1% |
| Fluid Retention |
3.1% |
| Syncope |
3.1% |
| Pulmonary Oedema |
2.8% |
| Anaemia |
2.6% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Oedema Peripheral |
2.3% |
| Sepsis |
2.3% |
| Myocardial Infarction |
2.1% |
| Atrial Fibrillation |
2.0% |
| Microalbuminuria |
2.0% |
| Urine Albumin/creatinine Ratio Increased |
2.0% |
| Respiratory Failure |
1.9% |
|
| Interacting |
| Product Used For Unknown Indication |
68.1% |
| Hypertension |
8.5% |
| Antiplatelet Therapy |
4.3% |
| Trigeminal Neuralgia |
4.3% |
| Angina Pectoris |
2.1% |
| Depression |
2.1% |
| Diabetes Mellitus |
2.1% |
| Hyperlipidaemia |
2.1% |
| Insomnia |
2.1% |
| Pneumonia |
2.1% |
| Prophylaxis |
2.1% |
|
| Cardiac Death |
33.3% |
| Drug Interaction |
16.7% |
| Hypotension |
16.7% |
| Left Ventricular Hypertrophy |
16.7% |
| Renal Impairment |
16.7% |
|
